Haojie Huang
Fujian Medical University(CN)Naval Medical Research Command(US)Mayo Clinic(US)Central South University(CN)University of Electronic Science and Technology of China(CN)Tianjin Chengjian University(CN)Second Military Medical University(CN)Shanghai Jiao Tong University(CN)Xiamen University(CN)Chinese Academy of Sciences(CN)North Central Cancer Treatment Group(US)WinnMed(US)Yanshan University(CN)Shanghai Changzheng Hospital(CN)Education Department of Fujian Province(CN)Changhai Hospital(CN)Beijing National Laboratory for Molecular Sciences(CN)Zhujiang Hospital(CN)Mayo Clinic in Arizona(US)Shanghai First People's Hospital(CN)Mayo Clinic in Florida(US)Education Department of Hunan Province(CN)Institute of Chemistry(CN)Xiangya Hospital Central South University(CN)Tongji Hospital(CN)University of Chinese Academy of Sciences(CN)First Affiliated Hospital Zhejiang University(CN)Southern Medical University(CN)Hubei University of Technology(CN)Zhejiang University(CN)Fuzhou University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways, Cancer, Lipids, and Metabolism, FOXO transcription factor regulation
Most-Cited Works
- → Dynamic FoxO transcription factors(2007)1,119 cited
- → CrossMap: a versatile tool for coordinate conversion between genome assemblies(2013)843 cited
- → Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation(2005)513 cited
- Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.(2002)
- → CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage(2006)336 cited
- → Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation(2017)299 cited
- → Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth(2014)